DENISE LINDSEY
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner FORT MYERS, FL NPI 1225548282
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner FL ABBVIE INC. All categories
General Payments — all program years on this page
$6,474.76
- Category: General Payments
- Program years: PY2021–2024
- Record count: 319
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,496.24 across 82 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,496.24 | 82 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $159.61 | 15 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $135.05 | 7 |
| Incyte Corporation | $107.53 | 5 |
| Daiichi Sankyo Inc. | $99.95 | 4 |
| PFIZER INC. | $97.82 | 5 |
| Gilead Sciences, Inc. | $89.14 | 4 |
| EISAI INC. | $86.74 | 4 |
| Merck Sharp & Dohme Corporation | $82.46 | 4 |
| Acerta Pharma LLC | $74.62 | 4 |
| Bayer HealthCare Pharmaceuticals Inc. | $54.51 | 3 |
| GENZYME CORPORATION | $54.42 | 2 |
| BeiGene USA, Inc. | $46.33 | 2 |
| Genentech USA, Inc. | $45.94 | 3 |
| SOBI, INC | $37.60 | 2 |
| Janssen Biotech, Inc. | $36.32 | 2 |
| E.R. Squibb & Sons, L.L.C. | $33.33 | 2 |
| Lilly USA, LLC | $26.53 | 1 |
| TerSera Therapeutics LLC | $26.29 | 1 |
| Alexion Pharmaceuticals, Inc. | $22.08 | 1 |
| Pharmacosmos Therapeutics Inc. | $20.90 | 1 |
| Epizyme, Inc. | $19.71 | 1 |
| JAZZ PHARMACEUTICALS INC. | $17.63 | 1 |
| Genmab U.S., Inc. | $17.42 | 1 |
| ARRAY BIOPHARMA INC | $16.72 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $15.98 | 1 |
| Sumitomo Pharma America, Inc. | $14.95 | 1 |
| TAIHO ONCOLOGY, INC. | $14.75 | 1 |
| EMD Serono, Inc. | $14.65 | 1 |
| Agios Pharmaceuticals, Inc. | $13.73 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.53 | 1 |
By program year
Records — PY2024 (82)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.